Search

Author/Creator Wright, Chris

2. A Phase 2a study evaluating the safety, tolerability, pharmacokinetics, and central nervous system activity of CY6463 when administered to participants with Alzheimer's disease with vascular pathology. (31st December 2021)

Authors:
Glasser, Chad; Chickering, Jennifer; Wilson, Phebe; Florine, Emily; Winrow, Chris; Wright, Chris
Journal:
Alzheimer's & dementia
Issue:
Volume 17(2021)Supplement 9
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Designing interoperable health information systems using Enterprise Architecture approach in resource‐limited countries: A literature review. (5th September 2018)

Authors:
Higman, Susan; Dwivedi, Vikas; Nsaghurwe, Alpha; Busiga, Moses; Sotter Rulagirwa, Hermes; Smith, Dasha; Wright, Chris; Nyinondi, Ssanyu; Nyella, Edwin
Journal:
International journal of health planning and management
Issue:
Volume 34:Number 1(2019)
Page Start:
e85
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. In Vitro Exposure Systems and Dosimetry Assessment Tools for Inhaled Tobacco Products: Workshop Proceedings, Conclusions and Paths Forward for In Vitro Model Use. Issue 3 (July 2017)

Authors:
Behrsing, Holger; Hill, Erin; Raabe, Hans; Tice, Raymond; Fitzpatrick, Suzanne; Devlin, Robert; Pinkerton, Kent; Oberdörster, Günter; Wright, Chris; Wieczorek, Roman; Aufderheide, Michaela; Steiner, Sandro; Krebs, Tobias; Asgharian, Bahman; Corley, Richard; Oldham, Michael; Adamson, Jason; Li, Xi...
Journal:
ATLA
Issue:
Volume 45:Issue 3(2017)
Page Start:
117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗